Clinical Trial Update: A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and preliminary efficacy of combining pertuzumab with erlotinib in locally advanced or metastatic non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Perjeta (pertuzumab)
• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-10-16